Exxonmobil Investment Management Inc. TX cut its position in shares of Express Scripts Holding Co. (NASDAQ:ESRX) by 1.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 160,917 shares of the company’s stock after selling 2,884 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Express Scripts Holding were worth $11,349,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. Magnetar Financial LLC bought a new stake in Express Scripts Holding during the first quarter worth about $266,000. Panagora Asset Management Inc. boosted its stake in shares of Express Scripts Holding by 12.0% in the first quarter. Panagora Asset Management Inc. now owns 354,866 shares of the company’s stock valued at $24,376,000 after buying an additional 37,893 shares during the period. Seven Eight Capital LLC boosted its stake in shares of Express Scripts Holding by 43.0% in the first quarter. Seven Eight Capital LLC now owns 18,970 shares of the company’s stock valued at $1,303,000 after buying an additional 5,700 shares during the period. Squarepoint Ops LLC acquired a new stake in shares of Express Scripts Holding during the first quarter valued at about $1,275,000. Finally, Cypress Capital Group boosted its stake in shares of Express Scripts Holding by 39.4% in the first quarter. Cypress Capital Group now owns 16,614 shares of the company’s stock valued at $1,141,000 after buying an additional 4,693 shares during the period. 88.11% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Shares of Express Scripts Holding Co. (NASDAQ:ESRX) traded up 0.44% during trading on Monday, reaching $76.10. The company had a trading volume of 2,577,371 shares. Express Scripts Holding Co. has a 52-week low of $64.46 and a 52-week high of $89.00. The firm has a 50-day moving average price of $71.00 and a 200-day moving average price of $73.75. The company has a market capitalization of $46.92 billion, a P/E ratio of 17.99 and a beta of 0.96.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, October 25th. The company reported $1.74 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.74. Express Scripts Holding had a return on equity of 24.99% and a net margin of 2.70%. The firm had revenue of $25.41 billion for the quarter, compared to analyst estimates of $25.48 billion. During the same period last year, the company earned $1.45 EPS. The firm’s quarterly revenue was up .7% on a year-over-year basis. On average, analysts predict that Express Scripts Holding Co. will post $6.39 EPS for the current fiscal year.

Several equities research analysts have issued reports on the stock. Zacks Investment Research cut shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th. Mizuho lifted their target price on shares of Express Scripts Holding from $77.00 to $82.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 2nd. Oppenheimer Holdings Inc. reaffirmed a “market perform” rating on shares of Express Scripts Holding in a research note on Wednesday, November 2nd. Barclays PLC lifted their target price on shares of Express Scripts Holding from $85.00 to $87.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 27th. Finally, Sanford C. Bernstein reaffirmed an “underperform” rating and set a $68.00 target price on shares of Express Scripts Holding in a research note on Tuesday, September 6th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and nine have issued a buy rating to the company’s stock. Express Scripts Holding has an average rating of “Hold” and an average price target of $82.05.

In other news, Director Woodrow A. Myers, Jr. sold 12,036 shares of Express Scripts Holding stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $70.40, for a total value of $847,334.40. Following the transaction, the director now directly owns 14,918 shares of the company’s stock, valued at approximately $1,050,227.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Christopher A. Mcginnis sold 1,785 shares of Express Scripts Holding stock in a transaction dated Monday, September 12th. The shares were sold at an average price of $70.77, for a total value of $126,324.45. Following the completion of the transaction, the vice president now directly owns 4,955 shares in the company, valued at $350,665.35. The disclosure for this sale can be found here. 0.54% of the stock is owned by company insiders.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

5 Day Chart for NASDAQ:ESRX

Receive News & Stock Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related stocks with our FREE daily email newsletter.